首页 > 最新文献

Journal of Korean Medical Science最新文献

英文 中文
Increased Risk of Hematologic Malignancy in Moderate to Severe Psoriasis in Relation to the Use of Systemic Immunosuppressants: A Nationwide Population-Based Matched Cohort Study. 中重度银屑病患者血液恶性肿瘤风险增加与使用全身免疫抑制剂有关:一项基于全国人群的匹配队列研究
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-15 DOI: 10.3346/jkms.2025.40.e315
Yu Ri Woo, Kyunghee Chae, Seowon Song, Subin Lee, Yu Jin Lee, Hoon Kang, Sukil Kim, Jung Eun Kim

Background: The relationship between cancer and the use of systemic immunosuppressants in psoriasis treatment has not well established. The aim of this study was to evaluate the association between the systemic immunosuppressants used in the treatment for psoriasis and the risk of certain cancers in Korean patients with moderate to severe psoriasis.

Methods: A retrospective cohort study was conducted involving 93,152 patients with moderate to severe psoriasis and 205,850 matched controls in Korea, using merged data from the National Health Insurance System, Health Insurance Review & Assessment Service, and Korea National Cancer Incidence Database from 2008 to 2018.

Results: The study observed a lower incidence of any cancer in moderate to severe psoriasis patients (2.4%) compared to the general population (2.99%). However, there was a higher risk of hematologic cancers, particularly Hodgkin's lymphoma, non-Hodgkin's lymphoma, leukemia, and cutaneous T cell lymphoma. Notably, methotrexate doses of ≥ 17.5 mg/week increased the risk of hematologic cancer risk by 7.546 times and cutaneous T cell lymphoma risk by 9.038 times, but cyclosporine and corticosteroids use did not show a significant association with increased incidence of hematologic cancers. Meanwhile, use of cyclosporine, methotrexate and corticosteroid did not significantly affect the risk of skin cancer among patients with psoriasis.

Conclusion: This study reveals an increased risk of hematologic cancers, such as cutaneous T cell lymphomas, associated with high-dose immunosuppressant use in moderate to severe psoriasis, underscoring the need for careful treatment management.

背景:银屑病治疗中使用全身免疫抑制剂与癌症之间的关系尚未得到很好的确定。本研究的目的是评估用于治疗银屑病的全身免疫抑制剂与韩国中度至重度银屑病患者某些癌症风险之间的关系。方法:回顾性队列研究纳入韩国93,152例中重度牛皮癣患者和205,850名匹配对照,使用2008年至2018年国民健康保险系统、健康保险审查与评估服务中心和韩国国家癌症发病率数据库的合并数据。结果:研究发现,与普通人群(2.99%)相比,中度至重度牛皮癣患者的任何癌症发生率(2.4%)都较低。然而,患血液学癌症的风险较高,特别是霍奇金淋巴瘤、非霍奇金淋巴瘤、白血病和皮肤T细胞淋巴瘤。值得注意的是,甲氨蝶呤剂量≥17.5 mg/周使血液学癌症风险增加7.546倍,使皮肤T细胞淋巴瘤风险增加9.038倍,但环孢素和皮质类固醇的使用与血液学癌症发病率增加没有显着关联。同时,使用环孢素、甲氨蝶呤和皮质类固醇对银屑病患者患皮肤癌的风险没有显著影响。结论:本研究揭示了中重度牛皮癣患者使用高剂量免疫抑制剂会增加血液学癌症(如皮肤T细胞淋巴瘤)的风险,强调了谨慎治疗管理的必要性。
{"title":"Increased Risk of Hematologic Malignancy in Moderate to Severe Psoriasis in Relation to the Use of Systemic Immunosuppressants: A Nationwide Population-Based Matched Cohort Study.","authors":"Yu Ri Woo, Kyunghee Chae, Seowon Song, Subin Lee, Yu Jin Lee, Hoon Kang, Sukil Kim, Jung Eun Kim","doi":"10.3346/jkms.2025.40.e315","DOIUrl":"10.3346/jkms.2025.40.e315","url":null,"abstract":"<p><strong>Background: </strong>The relationship between cancer and the use of systemic immunosuppressants in psoriasis treatment has not well established. The aim of this study was to evaluate the association between the systemic immunosuppressants used in the treatment for psoriasis and the risk of certain cancers in Korean patients with moderate to severe psoriasis.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted involving 93,152 patients with moderate to severe psoriasis and 205,850 matched controls in Korea, using merged data from the National Health Insurance System, Health Insurance Review & Assessment Service, and Korea National Cancer Incidence Database from 2008 to 2018.</p><p><strong>Results: </strong>The study observed a lower incidence of any cancer in moderate to severe psoriasis patients (2.4%) compared to the general population (2.99%). However, there was a higher risk of hematologic cancers, particularly Hodgkin's lymphoma, non-Hodgkin's lymphoma, leukemia, and cutaneous T cell lymphoma. Notably, methotrexate doses of ≥ 17.5 mg/week increased the risk of hematologic cancer risk by 7.546 times and cutaneous T cell lymphoma risk by 9.038 times, but cyclosporine and corticosteroids use did not show a significant association with increased incidence of hematologic cancers. Meanwhile, use of cyclosporine, methotrexate and corticosteroid did not significantly affect the risk of skin cancer among patients with psoriasis.</p><p><strong>Conclusion: </strong>This study reveals an increased risk of hematologic cancers, such as cutaneous T cell lymphomas, associated with high-dose immunosuppressant use in moderate to severe psoriasis, underscoring the need for careful treatment management.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 48","pages":"e315"},"PeriodicalIF":2.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708973/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145763068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical Use of Artificial Intelligence for Processing Medical Images. 人工智能在医学图像处理中的伦理应用。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-15 DOI: 10.3346/jkms.2025.40.e341
Yuliya Fedorchenko, Olena Zimba

Artificial intelligence (AI) tools employ prompts and algorithms to perform tasks that typically require human expertise, hypothesis formulation, and critical evaluation. AI enables rapid analysis of complex imaging data, automates segmentation and lesion detection, and supports real-time image-guided interventions. Deep learning architectures (CNNs, RNNs, U-Net, and transformer-based models) facilitate advanced image classification, reconstruction, and interpretation, achieving clinical accuracies above 90% in multiple domains, including coronavirus disease 2019, oncology, and rheumatology. Generative AI platforms (MedGAN, StyleGAN, CycleGAN, SinGAN-Seg) further support synthetic image creation and dataset augmentation, mitigating data scarcity while preserving patient privacy. However, the integration of AI in healthcare presents significant ethical challenges. Key concerns include algorithmic bias, patient privacy, transparency, accountability, and equitable access. Biases-such as annotation, automation, confirmation, demographic, and feedback-loop bias-can compromise diagnostic reliability and patient outcomes. Ethical deployment requires rigorous data governance, informed consent, anonymization, standardized validation frameworks, human oversight, and regulatory compliance. Maintaining interpretability and transparency of AI outputs is essential for clinical decision-making, while professional training and AI literacy are critical to mitigate overreliance and ensure patient safety.

人工智能(AI)工具采用提示和算法来执行通常需要人类专业知识、假设制定和批判性评估的任务。人工智能能够快速分析复杂的成像数据,自动分割和病变检测,并支持实时图像引导干预。深度学习架构(cnn、rnn、U-Net和基于变压器的模型)促进了高级图像分类、重建和解释,在包括2019冠状病毒病、肿瘤学和风湿病学在内的多个领域实现了90%以上的临床准确率。生成式人工智能平台(MedGAN、StyleGAN、CycleGAN、SinGAN-Seg)进一步支持合成图像创建和数据集增强,在保护患者隐私的同时缓解数据短缺。然而,人工智能在医疗保健领域的整合带来了重大的伦理挑战。关键问题包括算法偏见、患者隐私、透明度、问责制和公平获取。偏差——例如注释、自动化、确认、人口统计和反馈回路偏差——会损害诊断的可靠性和患者的结果。道德部署需要严格的数据治理、知情同意、匿名化、标准化验证框架、人工监督和法规遵从性。保持人工智能输出的可解释性和透明度对于临床决策至关重要,而专业培训和人工智能素养对于减轻过度依赖和确保患者安全至关重要。
{"title":"Ethical Use of Artificial Intelligence for Processing Medical Images.","authors":"Yuliya Fedorchenko, Olena Zimba","doi":"10.3346/jkms.2025.40.e341","DOIUrl":"10.3346/jkms.2025.40.e341","url":null,"abstract":"<p><p>Artificial intelligence (AI) tools employ prompts and algorithms to perform tasks that typically require human expertise, hypothesis formulation, and critical evaluation. AI enables rapid analysis of complex imaging data, automates segmentation and lesion detection, and supports real-time image-guided interventions. Deep learning architectures (CNNs, RNNs, U-Net, and transformer-based models) facilitate advanced image classification, reconstruction, and interpretation, achieving clinical accuracies above 90% in multiple domains, including coronavirus disease 2019, oncology, and rheumatology. Generative AI platforms (MedGAN, StyleGAN, CycleGAN, SinGAN-Seg) further support synthetic image creation and dataset augmentation, mitigating data scarcity while preserving patient privacy. However, the integration of AI in healthcare presents significant ethical challenges. Key concerns include algorithmic bias, patient privacy, transparency, accountability, and equitable access. Biases-such as annotation, automation, confirmation, demographic, and feedback-loop bias-can compromise diagnostic reliability and patient outcomes. Ethical deployment requires rigorous data governance, informed consent, anonymization, standardized validation frameworks, human oversight, and regulatory compliance. Maintaining interpretability and transparency of AI outputs is essential for clinical decision-making, while professional training and AI literacy are critical to mitigate overreliance and ensure patient safety.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 48","pages":"e341"},"PeriodicalIF":2.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708964/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Employment Status and Lung Function Among Coal-Powered Electrical Plant Workers: A 5-Year Follow-up Study. 燃煤电厂职工就业状况与肺功能:一项5年随访研究。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-15 DOI: 10.3346/jkms.2025.40.e322
Jia Ryu, Eun-A Kim, Kayoung Park, Yun-Keun Lee, Hyunjoo Kim

Background: Coal-powered electrical plant workers are exposed to coal dust in the entire work process. In South Korea, the processes with relatively high exposure to hazardous substances are mainly conducted by subcontractor employees. The harmful substances may cause pneumoconiosis, lung cancer, as well as a decrease in lung function. However, few studies have investigated changes in lung function among plant workers. The current study hypothesizes that the lung function of workers would be reduced by dust exposure and these reductions differ by employment status.

Methods: This study was conducted on 1,108 workers in coal-powered electrical plants who underwent lung function tests as a special health check-up from 2013 to 2018. The study population was divided into three groups according to the work they mainly perform. These groups were the contractor operator, subcontractor operator, and subcontractor maintenance worker. To compare the exposure level to hazardous substances, the exposure index was calculated with using the measurement data for the workplace environment. To confirm the change of lung function, this study used the repeated-measure analysis of variance.

Results: The subcontractor and the contractor had the highest and lowest exposure indices at 4.5 and 1.7, respectively. The lung function indicators significantly decreased among the subcontractor maintenance and operating workers compared with the contractor workers after 5 years. The pulmonary function with forced vital capacity (in liters) in subcontractors 1 and 2 decreased by 0.1 and 0.2 L, respectively. Forced expiratory volume in 1 second (in liters) also decreased in the subcontractors. In addition, the decrease in pulmonary function level over time differed according to each group because the interaction between time and employment status was statistically significant (P < 0.01).

Conclusion: These results suggest an association between coal dust and lung function deterioration. Also, differences in exposure can cause disparities in health outcomes even for workers in the same workplace.

背景:煤电工人在整个工作过程中都暴露在煤尘中。在韩国,接触有害物质较多的工序主要由分包商雇员进行。这些有害物质可引起尘肺病、肺癌以及肺功能下降。然而,很少有研究调查工厂工人肺功能的变化。目前的研究假设,工人的肺功能会因接触粉尘而降低,而这些降低程度因就业状况而异。方法:对2013 - 2018年1108名燃煤电厂职工进行肺功能专项健康检查。研究人群根据他们主要从事的工作分为三组。这些组是承包商操作员,分包商操作员和分包商维修工人。利用工作场所环境的测量数据,计算了暴露指数,以比较对有害物质的暴露水平。为了证实肺功能的改变,本研究采用重复测量方差分析。结果:分包商和承包商的暴露指数最高为4.5,最低为1.7。5年后,分包维修和操作工人的肺功能指标明显低于承包商工人。分包商1和分包商2的肺功能与用力肺活量(升)分别下降0.1和0.2 L。分包商1秒用力呼气量(升)也有所下降。此外,由于时间与工作状态之间的交互作用有统计学意义(P < 0.01),肺功能水平随时间的下降在各组之间存在差异。结论:煤尘与肺功能恶化有关。此外,即使在同一工作场所工作的工人,接触程度的差异也会导致健康结果的差异。
{"title":"Employment Status and Lung Function Among Coal-Powered Electrical Plant Workers: A 5-Year Follow-up Study.","authors":"Jia Ryu, Eun-A Kim, Kayoung Park, Yun-Keun Lee, Hyunjoo Kim","doi":"10.3346/jkms.2025.40.e322","DOIUrl":"10.3346/jkms.2025.40.e322","url":null,"abstract":"<p><strong>Background: </strong>Coal-powered electrical plant workers are exposed to coal dust in the entire work process. In South Korea, the processes with relatively high exposure to hazardous substances are mainly conducted by subcontractor employees. The harmful substances may cause pneumoconiosis, lung cancer, as well as a decrease in lung function. However, few studies have investigated changes in lung function among plant workers. The current study hypothesizes that the lung function of workers would be reduced by dust exposure and these reductions differ by employment status.</p><p><strong>Methods: </strong>This study was conducted on 1,108 workers in coal-powered electrical plants who underwent lung function tests as a special health check-up from 2013 to 2018. The study population was divided into three groups according to the work they mainly perform. These groups were the contractor operator, subcontractor operator, and subcontractor maintenance worker. To compare the exposure level to hazardous substances, the exposure index was calculated with using the measurement data for the workplace environment. To confirm the change of lung function, this study used the repeated-measure analysis of variance.</p><p><strong>Results: </strong>The subcontractor and the contractor had the highest and lowest exposure indices at 4.5 and 1.7, respectively. The lung function indicators significantly decreased among the subcontractor maintenance and operating workers compared with the contractor workers after 5 years. The pulmonary function with forced vital capacity (in liters) in subcontractors 1 and 2 decreased by 0.1 and 0.2 L, respectively. Forced expiratory volume in 1 second (in liters) also decreased in the subcontractors. In addition, the decrease in pulmonary function level over time differed according to each group because the interaction between time and employment status was statistically significant (<i>P</i> < 0.01).</p><p><strong>Conclusion: </strong>These results suggest an association between coal dust and lung function deterioration. Also, differences in exposure can cause disparities in health outcomes even for workers in the same workplace.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 48","pages":"e322"},"PeriodicalIF":2.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708965/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Human Skin Microbiome-Derived Strains as Topical Treatment for Acne: An In Vitro and In Vivo Study. 人体皮肤微生物来源菌株局部治疗痤疮的有效性和安全性:体外和体内研究。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-15 DOI: 10.3346/jkms.2025.40.e327
Sang Gyu Lee, Joo Hee Lee, Yujin Baek, Jaeryang Chu, Kyung Hwan Kim, Seoyoon Ham, Chang Hun Shin, Young In Lee

Background: The skin microbiome plays a crucial role in defending against pathogens and modulating immunity, and its dysregulation is linked to various skin conditions, including acne.

Methods: In this study, four previously identified strains-Staphylococcus epidermidis B424F-5, S. epidermidis BS47C-1, Dermacoccus profundi BS35F-3, and Streptococcus salivarius BS320F-4- were selected from a skin microbiome database of healthy individuals. The efficacy and safety of these strains against acne-related inflammation were evaluated using in vitro and in vivo animal model experiments.

Results: Cutibacterium acnes exposure increased the expression of acne-associated inflammatory mediators-such as IL-1β, IL-6, IL-8, COX-2, iNOS, and TNF-α-particularly in keratinocytes, without inducing cytotoxicity. Treatment with heat-killed S. epidermidis BS47C-1 (SE2), D. profundi BS35F-3 (DP), and S. salivarius BS320F-4 (SS) significantly reduced these markers in vitro. In vivo, topical application of the strains alleviated inflammation in a C. acnes-induced mouse model, with histological evidence of reduced erythema and immune cell infiltration. Bulk RNA sequencing of keratinocytes showed that SE2 and DP downregulated cytokine and interferon signaling while enhancing skin barrier and antimicrobial gene expression, suggesting a dual anti-inflammatory and barrier-supporting mechanism.

Conclusion: These results provide compelling evidence of the efficacy and safety of human skin microbiome-derived strains as potential topical treatments for acne. By targeting both microbial colonization and inflammatory pathways, these strains offer a promising avenue for the development of novel acne therapeutics.

背景:皮肤微生物群在抵御病原体和调节免疫力方面起着至关重要的作用,其失调与各种皮肤状况有关,包括痤疮。方法:在本研究中,从健康人群皮肤微生物群数据库中选择四种先前鉴定的菌株——表皮葡萄球菌B424F-5、表皮葡萄球菌BS47C-1、深度皮球菌BS35F-3和唾液链球菌BS320F-4。通过体外和体内动物模型实验,评价了这些菌株抗痤疮相关炎症的有效性和安全性。结果:痤疮表皮杆菌暴露增加了痤疮相关炎症介质的表达,如IL-1β、IL-6、IL-8、COX-2、iNOS和TNF-α,特别是在角质形成细胞中,而不诱导细胞毒性。热灭活表皮链球菌BS47C-1 (SE2)、深孔链球菌BS35F-3 (DP)和唾液链球菌BS320F-4 (SS)在体外显著降低了这些标志物。在体内,局部应用该菌株可减轻C.痤疮诱导的小鼠模型的炎症,组织学证据显示红斑和免疫细胞浸润减少。角质形成细胞的大量RNA测序显示,SE2和DP下调细胞因子和干扰素信号,同时增强皮肤屏障和抗菌基因的表达,表明其具有抗炎和支持屏障的双重机制。结论:这些结果提供了令人信服的证据,证明人类皮肤微生物来源的菌株作为潜在的局部治疗痤疮的有效性和安全性。通过靶向微生物定植和炎症途径,这些菌株为开发新型痤疮疗法提供了一条有希望的途径。
{"title":"Efficacy and Safety of Human Skin Microbiome-Derived Strains as Topical Treatment for Acne: An In Vitro and In Vivo Study.","authors":"Sang Gyu Lee, Joo Hee Lee, Yujin Baek, Jaeryang Chu, Kyung Hwan Kim, Seoyoon Ham, Chang Hun Shin, Young In Lee","doi":"10.3346/jkms.2025.40.e327","DOIUrl":"10.3346/jkms.2025.40.e327","url":null,"abstract":"<p><strong>Background: </strong>The skin microbiome plays a crucial role in defending against pathogens and modulating immunity, and its dysregulation is linked to various skin conditions, including acne.</p><p><strong>Methods: </strong>In this study, four previously identified strains-<i>Staphylococcus epidermidis</i> B424F-5, <i>S. epidermidis</i> BS47C-1, <i>Dermacoccus profundi</i> BS35F-3, and <i>Streptococcus salivarius</i> BS320F-4- were selected from a skin microbiome database of healthy individuals. The efficacy and safety of these strains against acne-related inflammation were evaluated using in vitro and in vivo animal model experiments.</p><p><strong>Results: </strong><i>Cutibacterium acnes</i> exposure increased the expression of acne-associated inflammatory mediators-such as IL-1β, IL-6, IL-8, COX-2, iNOS, and TNF-α-particularly in keratinocytes, without inducing cytotoxicity. Treatment with heat-killed <i>S. epidermidis</i> BS47C-1 (SE2), <i>D. profundi</i> BS35F-3 (DP), and <i>S. salivarius</i> BS320F-4 (SS) significantly reduced these markers in vitro. In vivo, topical application of the strains alleviated inflammation in a <i>C. acnes</i>-induced mouse model, with histological evidence of reduced erythema and immune cell infiltration. Bulk RNA sequencing of keratinocytes showed that SE2 and DP downregulated cytokine and interferon signaling while enhancing skin barrier and antimicrobial gene expression, suggesting a dual anti-inflammatory and barrier-supporting mechanism.</p><p><strong>Conclusion: </strong>These results provide compelling evidence of the efficacy and safety of human skin microbiome-derived strains as potential topical treatments for acne. By targeting both microbial colonization and inflammatory pathways, these strains offer a promising avenue for the development of novel acne therapeutics.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 48","pages":"e327"},"PeriodicalIF":2.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708972/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic and Therapeutic Potential of Nicotinamide N-Methyltransferase and Hypoxia Inducible Lipid Droplet Associated in Clear Cell Renal Cell Carcinoma. 烟酰胺n -甲基转移酶和缺氧诱导脂滴在透明细胞肾细胞癌中的预后和治疗潜力。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-15 DOI: 10.3346/jkms.2025.40.e333
Mingyu Kim, Geehyun Song, Jae Young Joung, Ho Kyung Seo, Hyung Ho Lee, Jinsoo Chung

Background: Clear cell renal cell carcinoma (ccRCC) is the most aggressive subtype of renal cancer, characterized by profound metabolic reprogramming and lipid accumulation. Despite therapeutic advancements, reliable prognostic biomarkers remain limited. This study investigates the prognostic and functional relevance of nicotinamide N-methyltransferase (NNMT), and hypoxia inducible lipid droplet associated (HILPDA) in ccRCC.

Methods: RNA sequencing was performed on tumor and matched normal tissues from 14 ccRCC patients. Differential gene expression and pathway enrichment analyses were conducted. Receiver operating characteristic (ROC) curves were generated to assess diagnostic value. Kaplan-Meier survival analysis using The Cancer Genome Atlas data evaluated prognostic significance. NNMT knockdown experiments were conducted in ccRCC cell lines (SNU1272 and Caki-1) to assess functional relevance.

Results: NNMT and HILPDA were significantly upregulated in tumor tissues. Pathway analyses revealed associations with lipid metabolism and biosynthesis. ROC analysis showed high diagnostic accuracy (NNMT area under the curve [AUC], 0.923; HILPDA AUC, 0.943). Kaplan-Meier analysis demonstrated that high NNMT expression correlated with worse overall and disease-specific survival (P < 0.001), whereas HILPDA expression showed no prognostic impact. NNMT knockdown significantly reduced cell viability (P < 0.001), supporting its role in tumor progression.

Conclusion: NNMT is a promising prognostic biomarker and potential therapeutic target in ccRCC, supported by transcriptomic, clinical, and functional validation. While the prognostic relevance of HILPDA remains inconclusive, its metabolic associations suggest potential biological significance. Further studies with larger cohorts and in vivo validation are warranted.

背景:透明细胞肾细胞癌(ccRCC)是肾癌中最具侵袭性的亚型,其特征是代谢重编程和脂质积累。尽管治疗取得了进步,但可靠的预后生物标志物仍然有限。本研究探讨了烟酰胺n -甲基转移酶(NNMT)和缺氧诱导脂滴相关(HILPDA)在ccRCC中的预后和功能相关性。方法:对14例ccRCC患者的肿瘤组织和匹配的正常组织进行RNA测序。进行差异基因表达和途径富集分析。生成受试者工作特征(ROC)曲线以评估诊断价值。Kaplan-Meier生存分析使用癌症基因组图谱数据评估预后意义。在ccRCC细胞系(SNU1272和Caki-1)中进行了NNMT敲低实验,以评估其功能相关性。结果:NNMT和HILPDA在肿瘤组织中表达显著上调。途径分析显示与脂质代谢和生物合成有关。ROC分析显示诊断准确率较高(NNMT曲线下面积[AUC], 0.923; HILPDA AUC, 0.943)。Kaplan-Meier分析显示,NNMT的高表达与较差的总体生存和疾病特异性生存相关(P < 0.001),而HILPDA的表达对预后没有影响。NNMT敲除显著降低细胞活力(P < 0.001),支持其在肿瘤进展中的作用。结论:经转录组学、临床和功能验证,NNMT是一种有前景的ccRCC预后生物标志物和潜在的治疗靶点。虽然HILPDA与预后的相关性仍不确定,但其代谢关联提示了潜在的生物学意义。进一步的研究需要更大的队列和体内验证。
{"title":"Prognostic and Therapeutic Potential of Nicotinamide N-Methyltransferase and Hypoxia Inducible Lipid Droplet Associated in Clear Cell Renal Cell Carcinoma.","authors":"Mingyu Kim, Geehyun Song, Jae Young Joung, Ho Kyung Seo, Hyung Ho Lee, Jinsoo Chung","doi":"10.3346/jkms.2025.40.e333","DOIUrl":"10.3346/jkms.2025.40.e333","url":null,"abstract":"<p><strong>Background: </strong>Clear cell renal cell carcinoma (ccRCC) is the most aggressive subtype of renal cancer, characterized by profound metabolic reprogramming and lipid accumulation. Despite therapeutic advancements, reliable prognostic biomarkers remain limited. This study investigates the prognostic and functional relevance of nicotinamide N-methyltransferase (NNMT), and hypoxia inducible lipid droplet associated (HILPDA) in ccRCC.</p><p><strong>Methods: </strong>RNA sequencing was performed on tumor and matched normal tissues from 14 ccRCC patients. Differential gene expression and pathway enrichment analyses were conducted. Receiver operating characteristic (ROC) curves were generated to assess diagnostic value. Kaplan-Meier survival analysis using The Cancer Genome Atlas data evaluated prognostic significance. NNMT knockdown experiments were conducted in ccRCC cell lines (SNU1272 and Caki-1) to assess functional relevance.</p><p><strong>Results: </strong>NNMT and HILPDA were significantly upregulated in tumor tissues. Pathway analyses revealed associations with lipid metabolism and biosynthesis. ROC analysis showed high diagnostic accuracy (NNMT area under the curve [AUC], 0.923; HILPDA AUC, 0.943). Kaplan-Meier analysis demonstrated that high NNMT expression correlated with worse overall and disease-specific survival (<i>P</i> < 0.001), whereas HILPDA expression showed no prognostic impact. NNMT knockdown significantly reduced cell viability (<i>P</i> < 0.001), supporting its role in tumor progression.</p><p><strong>Conclusion: </strong>NNMT is a promising prognostic biomarker and potential therapeutic target in ccRCC, supported by transcriptomic, clinical, and functional validation. While the prognostic relevance of HILPDA remains inconclusive, its metabolic associations suggest potential biological significance. Further studies with larger cohorts and in vivo validation are warranted.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 48","pages":"e333"},"PeriodicalIF":2.3,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145763133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Unmet Healthcare Needs With Depressive Symptoms and COVID-19 Pandemic-Related Factors Among Adults, 2009-2022: A Nationwide Study in Korea. 2009-2022年韩国成年人未满足的医疗需求与抑郁症状和COVID-19大流行相关因素的关系:一项全国性研究
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-08 DOI: 10.3346/jkms.2025.40.e307
Jiseung Kang, Jaeyu Park, Hyeon Jin Kim, Hayeon Lee, Guillaume Fond, Laurent Boyer, Masoud Rahmati, Christa J Nehs, Lee Smith, Dong Keon Yon

Background: To investigate the long-term trends in prevalence and pandemic-related factors of unmet healthcare needs among a nationwide large-scale cohort with or without depressive symptoms from the Korea Community Health Survey.

Methods: We analyzed 2,850,315 Korean adults aged 19 years or older, including individuals with or without depressive symptoms. Our study investigated the trends and risk factors for unmet healthcare needs among individuals, stratified by the presence of depressive symptoms during the pre-pandemic (2009-2019) and pandemic era (2020-2022). Weighted odds ratios and weighted regression slope coefficients (β) with 95% confidence intervals (CIs) were employed to analyze the prevalence of unmet healthcare needs.

Results: Of a total of 2,850,315 individuals (mean ± standard deviation age, 53.04 ± 17.43 years; male, 44.81%). Unmet healthcare needs decreased in both groups during the observation period. Individuals with depressive symptoms had a 2-3 times higher prevalence of unmet healthcare needs. The downward trend for those with depressive symptoms, from 34.55% (95% CI, 33.77-35.34) in 2009-2010 to 21.50% (20.91-22.09) in 2017-2019, reversed during the pandemic, increasing from 13.82% (12.95-14.69) in 2020 to 14.37% (13.62-15.12) in 2022.

Conclusion: The study highlights increased unmet healthcare needs among individuals with depressive symptoms during the pandemic, emphasizing the necessity for tailored policies and effective healthcare distribution to reduce barriers for vulnerable populations during global crises.

背景:调查韩国社区健康调查中有或无抑郁症状的全国性大规模队列中未满足医疗保健需求的流行率和大流行相关因素的长期趋势。方法:我们分析了2,850,315名年龄在19岁或以上的韩国成年人,包括有或没有抑郁症状的个体。我们的研究调查了个体未满足医疗保健需求的趋势和危险因素,并按大流行前(2009-2019年)和大流行时期(2020-2022年)抑郁症状的存在进行分层。采用加权优势比和加权回归斜率系数(β)和95%置信区间(ci)分析未满足医疗需求的发生率。结果:共2850315例(平均±标准差年龄53.04±17.43岁,男性44.81%)。在观察期间,两组未满足的医疗保健需求均有所减少。有抑郁症状的个体未满足医疗保健需求的患病率高出2-3倍。抑郁症状患者的下降趋势,从2009-2010年的34.55% (95% CI, 33.77-35.34)降至2017-2019年的21.50%(20.91-22.09),在大流行期间发生逆转,从2020年的13.82%(12.95-14.69)上升到2022年的14.37%(13.62-15.12)。结论:该研究突出了大流行期间抑郁症患者未满足的医疗保健需求增加,强调了制定量身定制的政策和有效的医疗保健分配的必要性,以减少全球危机期间弱势群体的障碍。
{"title":"Association of Unmet Healthcare Needs With Depressive Symptoms and COVID-19 Pandemic-Related Factors Among Adults, 2009-2022: A Nationwide Study in Korea.","authors":"Jiseung Kang, Jaeyu Park, Hyeon Jin Kim, Hayeon Lee, Guillaume Fond, Laurent Boyer, Masoud Rahmati, Christa J Nehs, Lee Smith, Dong Keon Yon","doi":"10.3346/jkms.2025.40.e307","DOIUrl":"10.3346/jkms.2025.40.e307","url":null,"abstract":"<p><strong>Background: </strong>To investigate the long-term trends in prevalence and pandemic-related factors of unmet healthcare needs among a nationwide large-scale cohort with or without depressive symptoms from the Korea Community Health Survey.</p><p><strong>Methods: </strong>We analyzed 2,850,315 Korean adults aged 19 years or older, including individuals with or without depressive symptoms. Our study investigated the trends and risk factors for unmet healthcare needs among individuals, stratified by the presence of depressive symptoms during the pre-pandemic (2009-2019) and pandemic era (2020-2022). Weighted odds ratios and weighted regression slope coefficients (β) with 95% confidence intervals (CIs) were employed to analyze the prevalence of unmet healthcare needs.</p><p><strong>Results: </strong>Of a total of 2,850,315 individuals (mean ± standard deviation age, 53.04 ± 17.43 years; male, 44.81%). Unmet healthcare needs decreased in both groups during the observation period. Individuals with depressive symptoms had a 2-3 times higher prevalence of unmet healthcare needs. The downward trend for those with depressive symptoms, from 34.55% (95% CI, 33.77-35.34) in 2009-2010 to 21.50% (20.91-22.09) in 2017-2019, reversed during the pandemic, increasing from 13.82% (12.95-14.69) in 2020 to 14.37% (13.62-15.12) in 2022.</p><p><strong>Conclusion: </strong>The study highlights increased unmet healthcare needs among individuals with depressive symptoms during the pandemic, emphasizing the necessity for tailored policies and effective healthcare distribution to reduce barriers for vulnerable populations during global crises.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 47","pages":"e307"},"PeriodicalIF":2.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Machine Learning Approach to Assist Early Diagnosis of Diffuse Panbronchiolitis. 一种新的机器学习方法辅助弥漫性泛细支气管炎的早期诊断。
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-08 DOI: 10.3346/jkms.2025.40.e311
Hwan Jin Lee, Kyung Joon Heo, Yeon Seok You, Kum Ju Chae, Jong Seung Kim, Jae Seok Jeong, Yong Chul Lee

Background: Diffuse panbronchiolitis (DPB) is a rare and progressive inflammatory lung disease affecting the small airways; however, it is often misdiagnosed as other respiratory conditions, such as nontuberculous mycobacterial infection or bronchiectasis. This study aimed to apply machine learning (ML) algorithms to improve early diagnostic accuracy for DPB.

Methods: ML algorithms were applied using clinical, laboratory, and radiological data from 99 patients with suspected DPB. Patients were categorized into two groups based on established diagnostic criteria and major diagnostic criteria for DPB without impaired lung function. Seven ML models were evaluated.

Results: The least absolute shrinkage and selection operator regression model demonstrated the highest predictive accuracy. The analysis identified two key diagnostic factors, allergic rhinitis and the presence of macronodules on computed tomography scans, both of which were strongly associated with DPB.

Conclusion: These results highlight the first application of ML in diagnosing DPB and underscore the significance of allergic rhinitis and macronodules as critical indicators for early detection. Incorporating ML techniques into clinical practice could improve the diagnostic accuracy and efficiency for rare diseases such as DPB. Further research involving larger patient datasets is recommended to validate these results and refine the diagnostic criteria for DPB.

背景:弥漫性泛细支气管炎(DPB)是一种影响小气道的罕见进行性炎性肺病;然而,它经常被误诊为其他呼吸系统疾病,如非结核性分枝杆菌感染或支气管扩张。本研究旨在应用机器学习(ML)算法提高DPB的早期诊断准确性。方法:对99例疑似DPB患者的临床、实验室和放射学资料进行ML算法分析。根据已建立的诊断标准和肺功能不受损的DPB主要诊断标准将患者分为两组。对7个ML模型进行评价。结果:最小绝对收缩和选择算子回归模型的预测精度最高。分析确定了两个关键的诊断因素,变应性鼻炎和计算机断层扫描中出现的大结节,这两个因素都与DPB密切相关。结论:这些结果突出了ML在诊断DPB中的首次应用,强调了变应性鼻炎和巨结节作为早期发现的关键指标的意义。将ML技术应用于临床,可以提高对DPB等罕见病的诊断准确性和效率。建议进一步研究涉及更大的患者数据集,以验证这些结果并完善DPB的诊断标准。
{"title":"A Novel Machine Learning Approach to Assist Early Diagnosis of Diffuse Panbronchiolitis.","authors":"Hwan Jin Lee, Kyung Joon Heo, Yeon Seok You, Kum Ju Chae, Jong Seung Kim, Jae Seok Jeong, Yong Chul Lee","doi":"10.3346/jkms.2025.40.e311","DOIUrl":"10.3346/jkms.2025.40.e311","url":null,"abstract":"<p><strong>Background: </strong>Diffuse panbronchiolitis (DPB) is a rare and progressive inflammatory lung disease affecting the small airways; however, it is often misdiagnosed as other respiratory conditions, such as nontuberculous mycobacterial infection or bronchiectasis. This study aimed to apply machine learning (ML) algorithms to improve early diagnostic accuracy for DPB.</p><p><strong>Methods: </strong>ML algorithms were applied using clinical, laboratory, and radiological data from 99 patients with suspected DPB. Patients were categorized into two groups based on established diagnostic criteria and major diagnostic criteria for DPB without impaired lung function. Seven ML models were evaluated.</p><p><strong>Results: </strong>The least absolute shrinkage and selection operator regression model demonstrated the highest predictive accuracy. The analysis identified two key diagnostic factors, allergic rhinitis and the presence of macronodules on computed tomography scans, both of which were strongly associated with DPB.</p><p><strong>Conclusion: </strong>These results highlight the first application of ML in diagnosing DPB and underscore the significance of allergic rhinitis and macronodules as critical indicators for early detection. Incorporating ML techniques into clinical practice could improve the diagnostic accuracy and efficiency for rare diseases such as DPB. Further research involving larger patient datasets is recommended to validate these results and refine the diagnostic criteria for DPB.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 47","pages":"e311"},"PeriodicalIF":2.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Mental Health-Related Emergency Department Visits Among Adolescents and Young Adults: A Nationwide, Population-Based Study in Korea, 2017-2021. 青少年和年轻人心理健康相关急诊科就诊趋势:2017-2021年韩国一项全国性、基于人群的研究
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-08 DOI: 10.3346/jkms.2025.40.e316
Hanna Park, Mi-Ra Oh, Eul-Hee Roh, Young-Jin Huh, Seok-In Hong, Youn-Jung Kim, Won Young Kim

Background: Trends in mental health-related emergency department (ED) use among adolescents and young adults in South Korea are largely unexplored. This study evaluated recent trends and characteristics of these ED visits.

Methods: This nationwide epidemiologic study used data from the National Emergency Department Information System in Korea, including patients who visited the ED to receive psychiatric consultation between 2017 and 2021. Adolescents and young adults were defined as 10-24 years old, and their characteristics and trends were compared with those of adult (≥ 25 years) patients.

Results: Among 117,997 patients, adolescents and young adults comprised 28.0% of the population. There was a significant increasing trend in ED visits between 2017 and 2021 among adolescents and young adults (4,737 to 8,787, P < 0.001), whereas the adult patient visits were stationary (16,798 to 16,313, P = 0.497). In the adolescents and young adults group, there was a greater predominance of females (67.1%), transfer from other facilities (10.8%), discharge to home after treatment (71.7%), and visits due to intentional self-harm (26.9%) than in the older age group. The most common diagnostic codes were F30-F39 (mood [affective] disorder; 43.2%), and the most common diagnosis was F32 (depressive episode), accounting for 17.7%. Diagnoses in the F30-39 category, especially F32, significantly increased each year (P < 0.001).

Conclusion: The study revealed that from 2017 to 2021, mental health-related ED visits for adolescents and young adults nearly doubled, especially for depression and mood disorders, with a significant increase among female patients. This highlights the need for tailored strategies and more psychiatric expertise in the ED.

背景:韩国青少年和年轻人使用精神健康相关急诊科(ED)的趋势在很大程度上尚未探索。本研究评估了这些急诊科就诊的最新趋势和特征。方法:这项全国性流行病学研究使用了韩国国家急诊科信息系统的数据,包括2017年至2021年间前往急诊科接受精神病学咨询的患者。青少年和青壮年被定义为10-24岁,并与成人(≥25岁)患者的特征和趋势进行比较。结果:117,997例患者中,青少年和青壮年占28.0%。2017年至2021年间,青少年和年轻人的急诊科就诊次数呈显著增加趋势(4737至8787次,P < 0.001),而成年患者的急诊科就诊次数保持平稳(16798至16313次,P = 0.497)。在青少年和青壮年组中,女性(67.1%)、从其他机构转移(10.8%)、治疗后出院(71.7%)和因故意自残而就诊(26.9%)的比例高于老年组。最常见的诊断代码为F30-F39(情绪[情感]障碍,占43.2%),最常见的诊断代码为F32(抑郁发作),占17.7%。F30-39类别的诊断,特别是F32,每年显著增加(P < 0.001)。结论:该研究显示,从2017年到2021年,青少年和年轻人的心理健康相关ED就诊人数几乎翻了一番,尤其是抑郁症和情绪障碍,其中女性患者显着增加。这凸显了急诊科需要量身定制的策略和更多的精神病学专业知识。
{"title":"Trends in Mental Health-Related Emergency Department Visits Among Adolescents and Young Adults: A Nationwide, Population-Based Study in Korea, 2017-2021.","authors":"Hanna Park, Mi-Ra Oh, Eul-Hee Roh, Young-Jin Huh, Seok-In Hong, Youn-Jung Kim, Won Young Kim","doi":"10.3346/jkms.2025.40.e316","DOIUrl":"10.3346/jkms.2025.40.e316","url":null,"abstract":"<p><strong>Background: </strong>Trends in mental health-related emergency department (ED) use among adolescents and young adults in South Korea are largely unexplored. This study evaluated recent trends and characteristics of these ED visits.</p><p><strong>Methods: </strong>This nationwide epidemiologic study used data from the National Emergency Department Information System in Korea, including patients who visited the ED to receive psychiatric consultation between 2017 and 2021. Adolescents and young adults were defined as 10-24 years old, and their characteristics and trends were compared with those of adult (≥ 25 years) patients.</p><p><strong>Results: </strong>Among 117,997 patients, adolescents and young adults comprised 28.0% of the population. There was a significant increasing trend in ED visits between 2017 and 2021 among adolescents and young adults (4,737 to 8,787, <i>P</i> < 0.001), whereas the adult patient visits were stationary (16,798 to 16,313, <i>P</i> = 0.497). In the adolescents and young adults group, there was a greater predominance of females (67.1%), transfer from other facilities (10.8%), discharge to home after treatment (71.7%), and visits due to intentional self-harm (26.9%) than in the older age group. The most common diagnostic codes were F30-F39 (mood [affective] disorder; 43.2%), and the most common diagnosis was F32 (depressive episode), accounting for 17.7%. Diagnoses in the F30-39 category, especially F32, significantly increased each year (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>The study revealed that from 2017 to 2021, mental health-related ED visits for adolescents and young adults nearly doubled, especially for depression and mood disorders, with a significant increase among female patients. This highlights the need for tailored strategies and more psychiatric expertise in the ED.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 47","pages":"e316"},"PeriodicalIF":2.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Isoniazid Resistance on Treatment Outcome Among People With Pulmonary Tuberculosis in Korea. 韩国肺结核患者异烟肼耐药性对治疗结果的影响
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-08 DOI: 10.3346/jkms.2025.40.e313
Jong Min Lee, Hyung Woo Kim, Eung Gu Lee, Yeonhee Park, Sung Soo Jung, Jin Woo Kim, Jee Youn Oh, Heayon Lee, Seung Hoon Kim, Sun-Hyung Kim, Jiwon Lyu, Sun Jung Kwon, Yun-Jeong Jeong, Dojin Kim, Hyeon-Kyoung Koo, Ganghee Chae, Sun Young Kyung, Sung Soon Lee, Jae Seuk Park, Ju Sang Kim, Jinsoo Min

Background: Isoniazid resistance is the most common type of ant-tuberculosis drug resistance, which is often neglected in clinical practice. This study aimed to evaluate the impact of isoniazid mono-resistant tuberculosis (Hr-TB) on the treatment outcomes of people with pulmonary tuberculosis.

Methods: People with pulmonary tuberculosis were enrolled from the Korea Tuberculosis Cohort (KTBC) registry and the multicenter prospective cohort study of pulmonary tuberculosis (COSMOTB). Isoniazid resistance was confirmed using drug susceptibility test results. The primary outcome was an unfavorable outcome, which defined as comprising death, failure, loss-to-follow-up, still-on-treatment, and not-evaluated. Logistic regression analysis was conducted to evaluate effect of isoniazid resistance on treatment outcomes. We also compared 2-month sputum negative culture conversion rate and incidence of adverse events between Hr-TB and drug-susceptible tuberculosis.

Results: From the KTBC and COSMOTB databases, 10,482 and 758 participants were included, respectively. Compared to drug-susceptible tuberculosis, Hr-TB had higher rates of unfavorable outcome in the KTBC (45.8% vs. 37.0%, P < 0.001) and COSMOTB (31.5% vs. 17.9%, P = 0.014). Multivariable logistic regression analysis showed significant association between isoniazid resistance and unfavorable outcome in the KTBC (adjusted odds ratio [aOR], 1.43; 95% confidence interval [CI], 1.24-1.65) and in the COSMOTB (aOR, 1.98; 95% CI, 1.02-3.85). Additional analyses on COSMOTB data showed that Hr-TB had more serious adverse drug reactions, while 2-month sputum culture conversion rates did not differ significantly.

Conclusion: Isoniazid resistance is significantly associated with unfavorable clinical outcomes.

背景:异烟肼耐药是最常见的抗结核药物耐药类型,但在临床实践中往往被忽视。本研究旨在评估异烟肼单耐药结核病(Hr-TB)对肺结核患者治疗结果的影响。方法:从韩国肺结核队列(KTBC)登记和肺结核多中心前瞻性队列研究(COSMOTB)中招募肺结核患者。药敏试验结果证实对异烟肼耐药。主要结局为不良结局,定义为包括死亡、失败、失去随访、仍在治疗和未评估。采用Logistic回归分析评价异烟肼耐药对治疗结果的影响。我们还比较了Hr-TB和药敏结核患者2个月痰培养阴性转化率和不良事件发生率。结果:从KTBC和COSMOTB数据库中分别纳入10,482和758名参与者。与药敏结核相比,Hr-TB在KTBC (45.8% vs. 37.0%, P < 0.001)和COSMOTB (31.5% vs. 17.9%, P = 0.014)中有更高的不良结局发生率。多变量logistic回归分析显示,异烟肼耐药与KTBC(校正优势比[aOR], 1.43; 95%可信区间[CI], 1.24-1.65)和COSMOTB (aOR, 1.98; 95% CI, 1.02-3.85)的不良结局之间存在显著关联。对COSMOTB数据的进一步分析表明,Hr-TB有更严重的药物不良反应,而2个月痰培养转化率没有显着差异。结论:异烟肼耐药与不良临床结果显著相关。
{"title":"Effect of Isoniazid Resistance on Treatment Outcome Among People With Pulmonary Tuberculosis in Korea.","authors":"Jong Min Lee, Hyung Woo Kim, Eung Gu Lee, Yeonhee Park, Sung Soo Jung, Jin Woo Kim, Jee Youn Oh, Heayon Lee, Seung Hoon Kim, Sun-Hyung Kim, Jiwon Lyu, Sun Jung Kwon, Yun-Jeong Jeong, Dojin Kim, Hyeon-Kyoung Koo, Ganghee Chae, Sun Young Kyung, Sung Soon Lee, Jae Seuk Park, Ju Sang Kim, Jinsoo Min","doi":"10.3346/jkms.2025.40.e313","DOIUrl":"10.3346/jkms.2025.40.e313","url":null,"abstract":"<p><strong>Background: </strong>Isoniazid resistance is the most common type of ant-tuberculosis drug resistance, which is often neglected in clinical practice. This study aimed to evaluate the impact of isoniazid mono-resistant tuberculosis (Hr-TB) on the treatment outcomes of people with pulmonary tuberculosis.</p><p><strong>Methods: </strong>People with pulmonary tuberculosis were enrolled from the Korea Tuberculosis Cohort (KTBC) registry and the multicenter prospective cohort study of pulmonary tuberculosis (COSMOTB). Isoniazid resistance was confirmed using drug susceptibility test results. The primary outcome was an unfavorable outcome, which defined as comprising death, failure, loss-to-follow-up, still-on-treatment, and not-evaluated. Logistic regression analysis was conducted to evaluate effect of isoniazid resistance on treatment outcomes. We also compared 2-month sputum negative culture conversion rate and incidence of adverse events between Hr-TB and drug-susceptible tuberculosis.</p><p><strong>Results: </strong>From the KTBC and COSMOTB databases, 10,482 and 758 participants were included, respectively. Compared to drug-susceptible tuberculosis, Hr-TB had higher rates of unfavorable outcome in the KTBC (45.8% vs. 37.0%, <i>P</i> < 0.001) and COSMOTB (31.5% vs. 17.9%, <i>P</i> = 0.014). Multivariable logistic regression analysis showed significant association between isoniazid resistance and unfavorable outcome in the KTBC (adjusted odds ratio [aOR], 1.43; 95% confidence interval [CI], 1.24-1.65) and in the COSMOTB (aOR, 1.98; 95% CI, 1.02-3.85). Additional analyses on COSMOTB data showed that Hr-TB had more serious adverse drug reactions, while 2-month sputum culture conversion rates did not differ significantly.</p><p><strong>Conclusion: </strong>Isoniazid resistance is significantly associated with unfavorable clinical outcomes.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 47","pages":"e313"},"PeriodicalIF":2.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Clinical Outcomes of ABO-Incompatible Kidney Transplantation in Patients With High Baseline Anti-A/B Antibody Titers. 高基线抗a /B抗体滴度患者abo血型不相容肾移植的长期临床结果
IF 2.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-08 DOI: 10.3346/jkms.2025.40.e308
Sang Hun Eum, Hanbi Lee, Eun Jeong Ko, Ji Won Min, Tae Hyun Ban, Hye Eun Yoon, Seok Joon Shin, Byung Ha Chung

Background: This study aimed to investigate the long-term clinical outcomes of ABO-incompatible kidney transplantation (ABO icKT) in patients with high baseline anti-A/B antibody titers.

Methods: This study included 271 cases of ABO icKT. Of these, 42 patients with a baseline antibody titer of ≥ 1:256 were assigned to the high-titer group, while the remaining 229 patients were categorized into the low-titer group. We compared the groups regarding the number of required pre-transplant plasmapheresis (PP) and intravenous immunoglobulin (IVIG) sessions. Clinical outcomes included post-operative bleeding, biopsy-proven acute rejection (BPAR), infectious complications, changes in allograft function, and long-term allograft and patient survival.

Results: The high-titer group required significantly more sessions of PP and IVIG than the low-titer group (8.74 ± 2.68 vs. 3.85 ± 1.64; P < 0.001). Following transplantation, anti-A/B antibody titers remained elevated in the high-titer group. There was no significant difference in post-operative bleeding between the two groups. However, the incidence of bacterial infection was higher in the high-titer group compared with the low-titer group (47.62% vs. 30.57%; P = 0.031), although this association was not significant in multivariable analysis. The incidence of total BPAR did not differ significantly; however, chronic active antibody-mediated rejection was more frequently observed in the high-titer group (7.14% vs. 0.87%; P = 0.028). Overall allograft and patient survival did not differ significantly between the two groups.

Conclusion: Patients with high baseline anti-A/B titers demonstrated comparable short-term and long-term patient and allograft outcomes to those in the low-titer group.

背景:本研究旨在探讨ABO不相容肾移植(ABO icKT)在高基线抗a /B抗体滴度患者中的长期临床结果。方法:本研究纳入271例ABO - ict。其中,42例基线抗体效价≥1:26 6 6的患者被分配到高效价组,而其余229例患者被划分到低效价组。我们比较了两组移植前血浆置换(PP)和静脉注射免疫球蛋白(IVIG)的次数。临床结果包括术后出血、活检证实的急性排斥反应(BPAR)、感染性并发症、同种异体移植物功能的改变以及同种异体移植物和患者的长期生存。结果:高滴度组所需的PP和IVIG疗程明显多于低滴度组(8.74±2.68比3.85±1.64;P < 0.001)。移植后,高滴度组的抗a /B抗体滴度仍然升高。两组术后出血无明显差异。然而,与低滴度组相比,高滴度组的细菌感染发生率更高(47.62% vs. 30.57%, P = 0.031),尽管这种关联在多变量分析中并不显著。总BPAR的发生率无显著性差异;然而,慢性主动抗体介导的排斥反应在高滴度组更常见(7.14%比0.87%;P = 0.028)。两组间同种异体移植和患者生存率无显著差异。结论:基线抗a /B滴度高的患者与低滴度组的短期和长期患者和同种异体移植预后相当。
{"title":"Long-Term Clinical Outcomes of ABO-Incompatible Kidney Transplantation in Patients With High Baseline Anti-A/B Antibody Titers.","authors":"Sang Hun Eum, Hanbi Lee, Eun Jeong Ko, Ji Won Min, Tae Hyun Ban, Hye Eun Yoon, Seok Joon Shin, Byung Ha Chung","doi":"10.3346/jkms.2025.40.e308","DOIUrl":"10.3346/jkms.2025.40.e308","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the long-term clinical outcomes of ABO-incompatible kidney transplantation (ABO icKT) in patients with high baseline anti-A/B antibody titers.</p><p><strong>Methods: </strong>This study included 271 cases of ABO icKT. Of these, 42 patients with a baseline antibody titer of ≥ 1:256 were assigned to the high-titer group, while the remaining 229 patients were categorized into the low-titer group. We compared the groups regarding the number of required pre-transplant plasmapheresis (PP) and intravenous immunoglobulin (IVIG) sessions. Clinical outcomes included post-operative bleeding, biopsy-proven acute rejection (BPAR), infectious complications, changes in allograft function, and long-term allograft and patient survival.</p><p><strong>Results: </strong>The high-titer group required significantly more sessions of PP and IVIG than the low-titer group (8.74 ± 2.68 vs. 3.85 ± 1.64; <i>P</i> < 0.001). Following transplantation, anti-A/B antibody titers remained elevated in the high-titer group. There was no significant difference in post-operative bleeding between the two groups. However, the incidence of bacterial infection was higher in the high-titer group compared with the low-titer group (47.62% vs. 30.57%; <i>P</i> = 0.031), although this association was not significant in multivariable analysis. The incidence of total BPAR did not differ significantly; however, chronic active antibody-mediated rejection was more frequently observed in the high-titer group (7.14% vs. 0.87%; <i>P</i> = 0.028). Overall allograft and patient survival did not differ significantly between the two groups.</p><p><strong>Conclusion: </strong>Patients with high baseline anti-A/B titers demonstrated comparable short-term and long-term patient and allograft outcomes to those in the low-titer group.</p>","PeriodicalId":16249,"journal":{"name":"Journal of Korean Medical Science","volume":"40 47","pages":"e308"},"PeriodicalIF":2.3,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685579/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145714764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Korean Medical Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1